Ginger Pigott

Shareholder; Vice Chair of Pharmaceutical, Medical Device & Health Care Litigation Practice, Greenberg Traurig

Ginger Pigott

Shareholder; Vice Chair of Pharmaceutical, Medical Device & Health Care Litigation Practice, Greenberg Traurig

Biography

Ginger Pigott is Vice Chair of the Pharmaceutical, Medical Device & Health Care Litigation Practice and focuses her practice on products liability litigation with an emphasis on the defense of complex medical device and pharmaceutical products.. She handles high-stakes, single-plaintiff cases (including through trial) and complex litigation, including MDLs, coordinated state actions and class actions working as both national and regional counsel. She also works with companies to reduce and eliminate litigation risk and has been instrumental in achieving early resolution by way of alternative dispute resolution and dispositive motions in a significant number of cases. She is also experienced in creating strategies for large litigation and document projects for geographically diverse clients on an international scale, as well as in developing alternative dispute resolution programs.

She has defended medical device products liability lawsuits involving a wide range of products, including spinal/biological devices, neurological devices, diabetes management devices, cardiovascular devices, implantable devices for various indications, cardiopulmonary bypass equipment, imaging equipment, as well as other external medical devices and related equipment. She is also experienced in defending products liability cases involving pharmaceutical drugs, nutraceuticals and biologics. In addition, Ginger has worked on a wide variety of other product liability matters, including welding products and consumables, airplanes, helicopters, rocket propelled parachute systems, automobiles, soft drinks, and video games. In both product cases and commercial litigation matters, she has experience with various unfair competition allegations including those derived from Section 17200 Unfair Competition Law (UCL) and the Consumer Legal Remedies Act (CLRA).